<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPW4SKFZFJ9YVFDLV1AJ]. www.edgarsuite.com -->
<HEAD>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P style='font:11pt Arial;margin:0;color:#000000'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:1080pt><TR><TD valign=middle style=width:1080pt;padding-right:2.8pt><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>UNITED STATES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>WASHINGTON, D.C. 20549</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>FORM 8-K</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>CURRENT REPORT</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>Pursuant to Section 13 or 15(d) of the</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>Securities Exchange Act of 1934</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style='border-bottom:1px solid #000000'><B>Date of Report: </B><B>April 12,2021</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>(Date of earliest event reported)</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><A name=bookmark=id.gjdgxs />&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>NUNZIA PHARMACEUTICAL COMPANY</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>(Exact name of registrant as specified in its charter)</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:624.45pt><TR><TD valign=top style=width:299.45pt;padding-left:6pt;padding-right:6pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>Utah</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>(State or other jurisdiction of incorporation or organization)</P>
</TD><TD valign=top style=width:325pt;padding-left:6pt;padding-right:6pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>87-0442090</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>(I.R.S. Employer Identification No.)</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:299.45pt;padding-left:6pt;padding-right:6pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>1627 West 14<SUP>th</SUP> Street, Long Beach, California</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=top style=width:325pt;padding-left:6pt;padding-right:6pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><B>90813</B></P>
</TD></TR>
<TR><TD valign=top style=width:299.45pt;padding-left:6pt;padding-right:6pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>(Address of principal executive offices)</P>
</TD><TD valign=top style=width:325pt;padding-left:6pt;padding-right:6pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>(Zip Code)</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style='border-bottom:1px solid #000000'><B>(714) 609 9117</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>(Registrant&#8217;s telephone number, including area code)</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000'><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;N/A</B></P>
<TABLE style=border-collapse:collapse;width:624.45pt><TR><TD valign=top bgcolor=#FFFFFF style='width:624.45pt;padding-left:5.4pt;padding-right:5.4pt;border-top:1pt solid #000000'><P style='font:10pt Times New Roman;margin:0;color:#000000'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Former name, former address and former fiscal year)</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;color:#000000'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt;color:#000000'>&#160;</P>
<TABLE style=border-collapse:collapse;width:1080pt><TR><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>[ ]</P>
</TD><TD valign=top style=width:1011.6pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
</TD></TR>
<TR><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>[ ]</P>
</TD><TD valign=top style=width:1011.6pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
</TD></TR>
<TR><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>[ ]</P>
</TD><TD valign=top style=width:1011.6pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
</TD></TR>
<TR><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD><TD valign=top style=width:34.2pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>[ ]</P>
</TD><TD valign=top style=width:1011.6pt;padding-right:0.8pt><P style='font:10pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin-top:6pt;margin-bottom:0pt;color:#000000'>&nbsp;</P>
<P style='font:9pt Times New Roman;margin:0;color:#000000'><B>&#160;</B></P>
<P align=justify style='font:9pt Times New Roman;margin:0;color:#000000'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</P>
<P align=justify style='font:9pt Times New Roman;margin:0;color:#000000'>&#160;</P>
<P align=justify style='font:9pt Times New Roman;margin:0;color:#000000'>&#160;</P>
<P align=justify style='font:9pt Times New Roman;margin:0;color:#000000'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]</P>
<TABLE style=border-collapse:collapse;width:1080pt><TR><TD valign=middle style=width:1080pt><P align=center style='font:10pt Times New Roman;margin:0'>&#160;</P>
</TD></TR>
</TABLE>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<TABLE style=border-collapse:collapse;width:1080pt><TR><TD valign=middle style=width:1080pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><B>Section 1 - Registrant&#8217;s Business and Operations </B></P>
<P style='font:10pt Times New Roman;margin:0'><B>Item 1.01 Entry into a Material Definitive Agreement. </B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-left:-4.5pt;margin-right:18pt'>On &nbsp;April &nbsp;12, &nbsp;2021, &nbsp;Global &nbsp;Wholehealth &nbsp;Partners &nbsp;Corporation &nbsp;(the &nbsp;&#8220;Company&#8221;) &nbsp;entered &nbsp;into &nbsp;a &nbsp;Mutual &nbsp;Sales &nbsp;and &nbsp;Marketing &nbsp;Agreement (&#8220;Agreement&#8221;) with Nunzia Pharmaceutical Inc. (&#8220;Nunzia&#8221;). Under the terms of the Agreement, each company has mutual abilities to share their products for sell under nonexclusive but favorable conditions and prices. The duration of the agreement is for an initial period of five years commencing on April 12, 2021. </P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-left:-4.5pt;margin-right:18pt'>The Company agreed to issue 5,000,000 shares of its restricted common stock to Nunzia and Nunzia agreed to issue 5,000,000 shares of its restricted common stock to the Company. </P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-left:-4.5pt;margin-right:18pt'>A copy of the agreement is furnished as Exhibit 10.1 </P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:-22.5pt;margin-left:18pt;margin-right:18pt'><B>Section 9 &#8211;&nbsp;Financial Statement and Exhibits Item </B></P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:-22.5pt;margin-left:18pt;margin-right:18pt'><B>9.01 Financial Statements and Exhibits.</B></P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:-22.5pt;margin-left:18pt;margin-right:18pt'><FONT style=color:#212529> Exhibit No. </FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Document Location &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Location</P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:-22.5pt;margin-left:18pt;margin-right:18pt'>10.1 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mutual Sales and Marketing Agreement between Global Wholehealth &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed Herewith</P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-left:-4.5pt;margin-right:18pt'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Partners Corporation and Nunzia Pharmaceutical Inc., dated April 12,</P>
<P align=justify style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-left:-4.5pt;margin-right:18pt'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2021</P>
<P align=justify style='font:9pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-indent:-22.5pt;margin-left:18pt;margin-right:18pt'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
<P align=center style='font:9pt Times New Roman;margin-top:0pt;margin-bottom:6pt;color:#000000'><B>SIGNATURES</B></P>
<P align=justify style='font:9pt Times New Roman;margin-top:0pt;margin-bottom:6pt;color:#000000'>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<TABLE style=border-collapse:collapse;width:1080pt><TR><TD colspan=2 valign=top style=width:738.65pt;padding-right:1.8pt><P style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:9pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt><B>NUNZIA PHARMACEUTICAL COMPANY</B></FONT></P>
</TD><TD valign=top style=width:341.35pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:109.25pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD><TD valign=top style=width:629.4pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD><TD valign=top style=width:341.35pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:109.25pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD><TD valign=top style=width:629.4pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD><TD valign=top style=width:341.35pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD></TR>
<TR><TD colspan=2 valign=top style=width:738.65pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>By: /</FONT><FONT style='font-size:9pt;border-bottom:1px solid #000000'>s/ Michael Mitsunaga</FONT></P>
</TD><TD valign=top style=width:341.35pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD></TR>
<TR><TD colspan=2 valign=top style=width:738.65pt;padding-left:18pt;padding-right:1.8pt><P style='font:9pt Times New Roman;margin:0'>Michael Mitsunaga</P>
<P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>President</FONT></P>
</TD><TD valign=top style=width:341.35pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD></TR>
<TR><TD colspan=2 valign=top style=width:738.65pt;padding-left:18pt;padding-right:1.8pt><P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:341.35pt;padding-right:0.8pt><P style='font:12pt Times New Roman;margin:0'><FONT style=font-size:9pt>&#160;</FONT></P>
</TD></TR>
</TABLE>
<P style='font:9pt Times New Roman;margin-top:6pt;margin-bottom:0pt;color:#000000'>Dated: April 19,2021</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt Verdana;margin-top:0pt;margin-bottom:8pt'>&nbsp;</P>
<P style='font:12pt Verdana;margin-top:0pt;margin-bottom:8pt'><FONT style='font-family:Times New Roman'><IMG src=nunzia202105078k_1.jpg width=594 height=769 alt='Picture 1' title='Picture 1'></FONT>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "nunzia-20210507_8k.htm", "secsgml_size_bytes": 17857}]
{"company-data": {"conformed-name": "NUNZIA PHARMACEUTICAL Co", "cik": "0000886093", "assigned-sic": "8741", "irs-number": "870442090", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-39175"}, "business-address": {"street1": "1627 WEST 14TH STREET", "city": "LONG BEACH", "state": "CA", "zip": "90813", "phone": "714-609-9117"}, "mail-address": {"street1": "1627 WEST 14TH STREET", "city": "LONG BEACH", "state": "CA", "zip": "90813"}, "former-company": [{"former-conformed-name": "Arizona Gold & Onyx Mining Co", "date-changed": "20100730"}, {"former-conformed-name": "VIKING CAPITAL GROUP INC", "date-changed": "19931102"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report:
April 12,2021
(Date of earliest event reported)
NUNZIA PHARMACEUTICAL COMPANY
(Exact name of registrant as specified in its charter)
Utah
(State or other jurisdiction of incorporation or organization)
87-0442090
(I.R.S. Employer Identification No.)
1627 West 14
th
Street, Long Beach, California
90813
(Address of principal executive offices)
(Zip Code)
(714) 609 9117
(Registrant's telephone number, including area code)
N/A
(Former name, former address and former fiscal year)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Section 1 - Registrant's Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On  April  12,  2021,  Global  Wholehealth  Partners  Corporation  (the  "Company")  entered  into  a  Mutual  Sales  and  Marketing  Agreement ("Agreement") with Nunzia Pharmaceutical Inc. ("Nunzia"). Under the terms of the Agreement, each company has mutual abilities to share their products for sell under nonexclusive but favorable conditions and prices. The duration of the agreement is for an initial period of five years commencing on April 12, 2021.
The Company agreed to issue 5,000,000 shares of its restricted common stock to Nunzia and Nunzia agreed to issue 5,000,000 shares of its restricted common stock to the Company.
A copy of the agreement is furnished as Exhibit 10.1
Section 9 – Financial Statement and Exhibits Item
9.01 Financial Statements and Exhibits.
Exhibit No.
Document Location                                                                                                 Location
10.1                     Mutual Sales and Marketing Agreement between Global Wholehealth                Filed Herewith
Partners Corporation and Nunzia Pharmaceutical Inc., dated April 12,
2021
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NUNZIA PHARMACEUTICAL COMPANY
By: /
s/ Michael Mitsunaga
Michael Mitsunaga
President
Dated: April 19,2021